ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count	gene_names
BP	GO:0071560	cellular response to transforming growth factor beta stimulus	8/29	274/18614	6.53607157334949e-09	6.25627412762351e-06	3.32537759779884e-06	1387/2033/2534/3065/4087/4088/6714/7157	8	CREBBP/EP300/FYN/HDAC1/SMAD2/SMAD3/SRC/TP53
BP	GO:0071559	response to transforming growth factor beta	8/29	280/18614	7.74291352428652e-09	6.25627412762351e-06	3.32537759779884e-06	1387/2033/2534/3065/4087/4088/6714/7157	8	CREBBP/EP300/FYN/HDAC1/SMAD2/SMAD3/SRC/TP53
BP	GO:0002223	stimulatory C-type lectin receptor signaling pathway	4/29	22/18614	3.40786939212521e-08	9.26871077108888e-06	4.92656851824422e-06	1387/2033/2534/6714	4	CREBBP/EP300/FYN/SRC
BP	GO:1990840	response to lectin	4/29	22/18614	3.40786939212521e-08	9.26871077108888e-06	4.92656851824422e-06	1387/2033/2534/6714	4	CREBBP/EP300/FYN/SRC
BP	GO:1990858	cellular response to lectin	4/29	22/18614	3.40786939212521e-08	9.26871077108888e-06	4.92656851824422e-06	1387/2033/2534/6714	4	CREBBP/EP300/FYN/SRC
BP	GO:0007179	transforming growth factor beta receptor signaling pathway	7/29	218/18614	3.44135300906765e-08	9.26871077108888e-06	4.92656851824422e-06	1387/2033/3065/4087/4088/6714/7157	7	CREBBP/EP300/HDAC1/SMAD2/SMAD3/SRC/TP53
BP	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	6/29	148/18614	9.32260965423814e-08	2.1217337851092e-05	1.12775844753069e-05	1387/2033/3065/4087/4088/7157	6	CREBBP/EP300/HDAC1/SMAD2/SMAD3/TP53
BP	GO:1903844	regulation of cellular response to transforming growth factor beta stimulus	6/29	151/18614	1.05036325995505e-07	2.1217337851092e-05	1.12775844753069e-05	1387/2033/3065/4087/4088/7157	6	CREBBP/EP300/HDAC1/SMAD2/SMAD3/TP53
BP	GO:0002757	immune response-activating signaling pathway	8/29	423/18614	1.88003247621901e-07	3.37570275729991e-05	1.7942766088827e-05	11119/1387/2033/2099/2534/2885/5594/6714	8	BTN3A1/CREBBP/EP300/ESR1/FYN/GRB2/MAPK1/SRC
BP	GO:0002764	immune response-regulating signaling pathway	8/29	450/18614	3.01257381177869e-07	4.36840376141129e-05	2.32192383357974e-05	11119/1387/2033/2099/2534/2885/5594/6714	8	BTN3A1/CREBBP/EP300/ESR1/FYN/GRB2/MAPK1/SRC
BP	GO:0002429	immune response-activating cell surface receptor signaling pathway	7/29	302/18614	3.17223521591818e-07	4.36840376141129e-05	2.32192383357974e-05	11119/1387/2033/2534/2885/5594/6714	7	BTN3A1/CREBBP/EP300/FYN/GRB2/MAPK1/SRC
BP	GO:0048511	rhythmic process	7/29	303/18614	3.24386417926581e-07	4.36840376141129e-05	2.32192383357974e-05	1387/1457/2033/2099/3065/6714/7157	7	CREBBP/CSNK2A1/EP300/ESR1/HDAC1/SRC/TP53
BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	7/29	329/18614	5.6486939504875e-07	7.02176109537523e-05	3.73225446445166e-05	11119/1387/2033/2534/2885/5594/6714	7	BTN3A1/CREBBP/EP300/FYN/GRB2/MAPK1/SRC
BP	GO:0002253	activation of immune response	8/29	495/18614	6.20327396861899e-07	7.16035052377735e-05	3.80591846495722e-05	11119/1387/2033/2099/2534/2885/5594/6714	8	BTN3A1/CREBBP/EP300/ESR1/FYN/GRB2/MAPK1/SRC
BP	GO:0030518	intracellular steroid hormone receptor signaling pathway	5/29	115/18614	8.69953411198073e-07	9.37229808330724e-05	4.98162795465002e-05	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:2001233	regulation of apoptotic signaling pathway	7/29	381/18614	1.50749419901414e-06	0.000152256914100429	8.09286359470751e-05	367/1457/1984/3065/9821/6714/7157	7	AR/CSNK2A1/EIF5A/HDAC1/RB1CC1/SRC/TP53
BP	GO:0043401	steroid hormone mediated signaling pathway	5/29	135/18614	1.92332502179822e-06	0.00018089774104912	9.61520041011477e-05	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	7/29	398/18614	2.01495008594317e-06	0.00018089774104912	9.61520041011477e-05	1387/2033/3065/4087/4088/6714/7157	7	CREBBP/EP300/HDAC1/SMAD2/SMAD3/SRC/TP53
BP	GO:0061180	mammary gland epithelium development	4/29	68/18614	3.61091704187693e-06	0.000291644930534437	0.000155017107423203	367/2099/5594/6714	4	AR/ESR1/MAPK1/SRC
BP	GO:1902893	regulation of miRNA transcription	4/29	68/18614	3.61091704187693e-06	0.000291644930534437	0.000155017107423203	367/2099/4088/7157	4	AR/ESR1/SMAD3/TP53
BP	GO:0061614	miRNA transcription	4/29	69/18614	3.82900804768674e-06	0.000291644930534437	0.000155017107423203	367/2099/4088/7157	4	AR/ESR1/SMAD3/TP53
BP	GO:0048732	gland development	7/29	441/18614	3.97041365826585e-06	0.000291644930534437	0.000155017107423203	367/2099/5594/9821/4087/4088/6714	7	AR/ESR1/MAPK1/RB1CC1/SMAD2/SMAD3/SRC
BP	GO:0033143	regulation of intracellular steroid hormone receptor signaling pathway	4/29	72/18614	4.54199465517454e-06	0.000319124494033133	0.000169623232888898	367/2033/3065/6714	4	AR/EP300/HDAC1/SRC
BP	GO:0060444	branching involved in mammary gland duct morphogenesis	3/29	22/18614	5.13266842815825e-06	0.000345599674162655	0.000183695501639348	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	6/29	301/18614	5.90683185356986e-06	0.000367132318283419	0.000195140679858826	1387/2033/3065/4087/4088/7157	6	CREBBP/EP300/HDAC1/SMAD2/SMAD3/TP53
BP	GO:0097193	intrinsic apoptotic signaling pathway	6/29	301/18614	5.90683185356986e-06	0.000367132318283419	0.000195140679858826	1026/1984/2033/3065/6714/7157	6	CDKN1A/EIF5A/EP300/HDAC1/SRC/TP53
BP	GO:0002220	innate immune response activating cell surface receptor signaling pathway	4/29	78/18614	6.25701293136424e-06	0.000374493811003134	0.000199053510798956	1387/2033/2534/6714	4	CREBBP/EP300/FYN/SRC
BP	GO:0036120	cellular response to platelet-derived growth factor stimulus	3/29	24/18614	6.73167164445712e-06	0.000388513620622954	0.000206505415860038	2534/3065/6714	3	FYN/HDAC1/SRC
BP	GO:2000628	regulation of miRNA metabolic process	4/29	81/18614	7.27449232288094e-06	0.000405364813578469	0.000215462277149577	367/2099/4088/7157	4	AR/ESR1/SMAD3/TP53
BP	GO:0007492	endoderm development	4/29	83/18614	8.01750103116026e-06	0.000417944569882419	0.000222148755226716	2885/3065/4087/4088	4	GRB2/HDAC1/SMAD2/SMAD3
BP	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	4/29	83/18614	8.01750103116026e-06	0.000417944569882419	0.000222148755226716	1026/1984/2033/7157	4	CDKN1A/EIF5A/EP300/TP53
BP	GO:0036119	response to platelet-derived growth factor	3/29	26/18614	8.62930344149808e-06	0.000425312502807933	0.000226065009309063	2534/3065/6714	3	FYN/HDAC1/SRC
BP	GO:0031647	regulation of protein stability	6/29	322/18614	8.68521818852834e-06	0.000425312502807933	0.000226065009309063	1387/2033/5594/4088/6714/7157	6	CREBBP/EP300/MAPK1/SMAD3/SRC/TP53
BP	GO:0071478	cellular response to radiation	5/29	191/18614	1.04942921767506e-05	0.000496955872632234	0.000264145383056216	1026/1387/2033/2885/7157	5	CDKN1A/CREBBP/EP300/GRB2/TP53
BP	GO:0009755	hormone-mediated signaling pathway	5/29	192/18614	1.07632769443863e-05	0.000496955872632234	0.000264145383056216	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:0034644	cellular response to UV	4/29	93/18614	1.26025146262609e-05	0.000561684160254337	0.000298550205033572	1026/1387/2033/7157	4	CDKN1A/CREBBP/EP300/TP53
BP	GO:0090287	regulation of cellular response to growth factor stimulus	6/29	345/18614	1.28603427781005e-05	0.000561684160254337	0.000298550205033572	1387/2033/3065/4087/4088/7157	6	CREBBP/EP300/HDAC1/SMAD2/SMAD3/TP53
BP	GO:0060603	mammary gland duct morphogenesis	3/29	30/18614	1.34186409178766e-05	0.000570645361139172	0.000303313323794661	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0010586	miRNA metabolic process	4/29	97/18614	1.48911816657387e-05	0.000617029476200866	0.000327967725755541	367/2099/4088/7157	4	AR/ESR1/SMAD3/TP53
BP	GO:0002758	innate immune response-activating signaling pathway	5/29	209/18614	1.62209528538132e-05	0.0006393429222381	0.000339827921147922	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0071383	cellular response to steroid hormone stimulus	5/29	209/18614	1.62209528538132e-05	0.0006393429222381	0.000339827921147922	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:1901653	cellular response to peptide	6/29	375/18614	2.06121975560383e-05	0.000793078839298999	0.000421542686860333	2534/2885/5594/6714/7157/7532	6	FYN/GRB2/MAPK1/SRC/TP53/YWHAG
BP	GO:2000279	negative regulation of DNA biosynthetic process	3/29	37/18614	2.54928966851493e-05	0.000958058628911657	0.000509233872584622	1026/6714/7157	3	CDKN1A/SRC/TP53
BP	GO:0002218	activation of innate immune response	5/29	233/18614	2.73559580238959e-05	0.000982382848147019	0.000522162847894716	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:2001234	negative regulation of apoptotic signaling pathway	5/29	233/18614	2.73559580238959e-05	0.000982382848147019	0.000522162847894716	367/1457/3065/9821/6714	5	AR/CSNK2A1/HDAC1/RB1CC1/SRC
BP	GO:0001701	in utero embryonic development	6/29	398/18614	2.88114130122584e-05	0.00101215746582195	0.000537988856247206	367/2885/5594/4087/4088/7157	6	AR/GRB2/MAPK1/SMAD2/SMAD3/TP53
BP	GO:2000278	regulation of DNA biosynthetic process	4/29	121/18614	3.55814637929505e-05	0.00122339671254059	0.000650268184883484	1026/5594/6714/7157	4	CDKN1A/MAPK1/SRC/TP53
BP	GO:0071482	cellular response to light stimulus	4/29	127/18614	4.30063557502499e-05	0.00142258723319162	0.000756143292264436	1026/1387/2033/7157	4	CDKN1A/CREBBP/EP300/TP53
BP	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3/29	44/18614	4.31353802143499e-05	0.00142258723319162	0.000756143292264436	1026/2033/7157	3	CDKN1A/EP300/TP53
BP	GO:0060443	mammary gland morphogenesis	3/29	45/18614	4.61681092844501e-05	0.00149215329207343	0.00079311951949708	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0030521	androgen receptor signaling pathway	3/29	47/18614	5.2646215387886e-05	0.0016052129069212	0.000853213738957596	367/2033/3065	3	AR/EP300/HDAC1
BP	GO:0035196	miRNA processing	3/29	47/18614	5.2646215387886e-05	0.0016052129069212	0.000853213738957596	4087/4088/7157	3	SMAD2/SMAD3/TP53
BP	GO:0051972	regulation of telomerase activity	3/29	47/18614	5.2646215387886e-05	0.0016052129069212	0.000853213738957596	5594/6714/7157	3	MAPK1/SRC/TP53
BP	GO:0031648	protein destabilization	3/29	48/18614	5.6097196001783e-05	0.00165094349586219	0.000877520774246708	1387/2033/6714	3	CREBBP/EP300/SRC
BP	GO:0030879	mammary gland development	4/29	136/18614	5.61892897725374e-05	0.00165094349586219	0.000877520774246708	367/2099/5594/6714	4	AR/ESR1/MAPK1/SRC
BP	GO:0048009	insulin-like growth factor receptor signaling pathway	3/29	50/18614	6.34369267086567e-05	0.00183060845644981	0.000973017522448569	367/2885/5594	3	AR/GRB2/MAPK1
BP	GO:1902895	positive regulation of miRNA transcription	3/29	51/18614	6.73312048507087e-05	0.00190889871997799	0.00101463089858132	367/4088/7157	3	AR/SMAD3/TP53
BP	GO:0030520	intracellular estrogen receptor signaling pathway	3/29	54/18614	7.9944596184067e-05	0.00221530969125093	0.00117749655293171	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0001666	response to hypoxia	5/29	293/18614	8.13486662187608e-05	0.00221530969125093	0.00117749655293171	1387/2033/4088/6714/7157	5	CREBBP/EP300/SMAD3/SRC/TP53
BP	GO:2000377	regulation of reactive oxygen species metabolic process	4/29	150/18614	8.22515974474355e-05	0.00221530969125093	0.00117749655293171	1026/2534/2885/7157	4	CDKN1A/FYN/GRB2/TP53
BP	GO:0030522	intracellular receptor signaling pathway	5/29	299/18614	8.95066799478469e-05	0.00233643488117851	0.00124187784200213	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:0045089	positive regulation of innate immune response	5/29	300/18614	9.09255173880496e-05	0.00233643488117851	0.00124187784200213	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0009411	response to UV	4/29	154/18614	9.10862608380237e-05	0.00233643488117851	0.00124187784200213	1026/1387/2033/7157	4	CDKN1A/CREBBP/EP300/TP53
BP	GO:0034504	protein localization to nucleus	5/29	304/18614	9.6775213428482e-05	0.00244357413906917	0.00129882523285594	1026/2534/4088/6714/7157	5	CDKN1A/FYN/SMAD3/SRC/TP53
BP	GO:0036293	response to decreased oxygen levels	5/29	306/18614	9.98067189025261e-05	0.00248134858071511	0.00131890336233945	1387/2033/4088/6714/7157	5	CREBBP/EP300/SMAD3/SRC/TP53
BP	GO:0007440	foregut morphogenesis	2/29	10/18614	0.000104652996892611	0.0024870476908597	0.00132193259232772	4087/4088	2	SMAD2/SMAD3
BP	GO:0048340	paraxial mesoderm morphogenesis	2/29	10/18614	0.000104652996892611	0.0024870476908597	0.00132193259232772	4087/4088	2	SMAD2/SMAD3
BP	GO:0051974	negative regulation of telomerase activity	2/29	10/18614	0.000104652996892611	0.0024870476908597	0.00132193259232772	6714/7157	2	SRC/TP53
BP	GO:2000630	positive regulation of miRNA metabolic process	3/29	60/18614	0.000109602326701324	0.00256691826013536	0.00136438594337575	367/4088/7157	3	AR/SMAD3/TP53
BP	GO:0060736	prostate gland growth	2/29	11/18614	0.000127785595158564	0.00290847213769351	0.00154593099554319	367/2099	2	AR/ESR1
BP	GO:0072584	caveolin-mediated endocytosis	2/29	11/18614	0.000127785595158564	0.00290847213769351	0.00154593099554319	5594/6714	2	MAPK1/SRC
BP	GO:0002833	positive regulation of response to biotic stimulus	5/29	327/18614	0.000136258171317464	0.00305823895623641	0.00162553607887501	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0072331	signal transduction by p53 class mediator	4/29	173/18614	0.000142747679324658	0.00311730067281955	0.00165692896627199	1026/1984/2033/7157	4	CDKN1A/EIF5A/EP300/TP53
BP	GO:2001242	regulation of intrinsic apoptotic signaling pathway	4/29	173/18614	0.000142747679324658	0.00311730067281955	0.00165692896627199	1984/3065/6714/7157	4	EIF5A/HDAC1/SRC/TP53
BP	GO:0001756	somitogenesis	3/29	66/18614	0.000145646022803274	0.00313818630466787	0.00166803024010486	2033/4088/7157	3	EP300/SMAD3/TP53
BP	GO:0070482	response to oxygen levels	5/29	333/18614	0.000148344685386884	0.00315427646822638	0.00167658259384623	1387/2033/4088/6714/7157	5	CREBBP/EP300/SMAD3/SRC/TP53
BP	GO:0052548	regulation of endopeptidase activity	5/29	336/18614	0.000154688277424468	0.00324644488724599	0.00172557258206926	1457/2534/3065/4088/6714	5	CSNK2A1/FYN/HDAC1/SMAD3/SRC
BP	GO:0048545	response to steroid hormone	5/29	339/18614	0.000161238058736216	0.00325700878647156	0.0017311875780099	367/2033/2099/3065/6714	5	AR/EP300/ESR1/HDAC1/SRC
BP	GO:0071214	cellular response to abiotic stimulus	5/29	339/18614	0.000161238058736216	0.00325700878647156	0.0017311875780099	1026/1387/2033/2885/7157	5	CDKN1A/CREBBP/EP300/GRB2/TP53
BP	GO:0104004	cellular response to environmental stimulus	5/29	339/18614	0.000161238058736216	0.00325700878647156	0.0017311875780099	1026/1387/2033/2885/7157	5	CDKN1A/CREBBP/EP300/GRB2/TP53
BP	GO:0043627	response to estrogen	3/29	70/18614	0.000173500034313433	0.00341922018842082	0.00181740729139617	367/2033/2099	3	AR/EP300/ESR1
BP	GO:2000379	positive regulation of reactive oxygen species metabolic process	3/29	70/18614	0.000173500034313433	0.00341922018842082	0.00181740729139617	1026/2885/7157	3	CDKN1A/GRB2/TP53
BP	GO:0007183	SMAD protein complex assembly	2/29	13/18614	0.00018087311791186	0.00346337559725864	0.0018408770761875	4087/4088	2	SMAD2/SMAD3
BP	GO:0070918	regulatory ncRNA processing	3/29	71/18614	0.000180964994219133	0.00346337559725864	0.0018408770761875	4087/4088/7157	3	SMAD2/SMAD3/TP53
BP	GO:0070661	leukocyte proliferation	5/29	348/18614	0.000182170127331055	0.00346337559725864	0.0018408770761875	11119/1026/2534/5594/7157	5	BTN3A1/CDKN1A/FYN/MAPK1/TP53
BP	GO:0061138	morphogenesis of a branching epithelium	4/29	188/18614	0.000196440375881006	0.00369125171422913	0.00196199934784456	367/2099/2885/6714	4	AR/ESR1/GRB2/SRC
BP	GO:0030308	negative regulation of cell growth	4/29	191/18614	0.000208714547142848	0.00387681273773383	0.00206063001171886	978/1026/4088/7157	4	CDA/CDKN1A/SMAD3/TP53
BP	GO:0071479	cellular response to ionizing radiation	3/29	75/18614	0.000212905733683934	0.00390972347310497	0.00207812295079055	1026/2885/7157	3	CDKN1A/GRB2/TP53
BP	GO:0031334	positive regulation of protein-containing complex assembly	4/29	195/18614	0.000225929856044457	0.00410227693671734	0.00218047028423746	2099/2885/6714/7157	4	ESR1/GRB2/SRC/TP53
BP	GO:0007369	gastrulation	4/29	196/18614	0.000230388944033273	0.00413676148397522	0.00219879974656317	2885/4087/4088/7157	4	GRB2/SMAD2/SMAD3/TP53
BP	GO:0051098	regulation of binding	5/29	369/18614	0.000239097534131204	0.00420681949084898	0.00223603745735589	1026/2033/4087/4088/6714	5	CDKN1A/EP300/SMAD2/SMAD3/SRC
BP	GO:0071897	DNA biosynthetic process	4/29	198/18614	0.000239497149231501	0.00420681949084898	0.00223603745735589	1026/5594/6714/7157	4	CDKN1A/MAPK1/SRC/TP53
BP	GO:0006206	pyrimidine nucleobase metabolic process	2/29	15/18614	0.00024301275544386	0.00422267325588471	0.0022444641589382	978/5594	2	CDA/MAPK1
BP	GO:0045088	regulation of innate immune response	5/29	373/18614	0.000251326027208376	0.00431459302338065	0.00229332198220337	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0050851	antigen receptor-mediated signaling pathway	4/29	201/18614	0.000253642535409135	0.00431459302338065	0.00229332198220337	11119/2534/2885/5594	4	BTN3A1/FYN/GRB2/MAPK1
BP	GO:0001763	morphogenesis of a branching structure	4/29	203/18614	0.000263401096781814	0.00443391846249387	0.00235674665541623	367/2099/2885/6714	4	AR/ESR1/GRB2/SRC
BP	GO:0038092	nodal signaling pathway	2/29	16/18614	0.000277460549573993	0.00459310345024421	0.00244135774843621	4087/4088	2	SMAD2/SMAD3
BP	GO:2000241	regulation of reproductive process	4/29	206/18614	0.000278542164680651	0.00459310345024421	0.00244135774843621	367/246184/2099/6714	4	AR/CDC26/ESR1/SRC
BP	GO:0009952	anterior/posterior pattern specification	4/29	209/18614	0.000294300095086266	0.00480392882484248	0.00255341709293347	2033/4087/4088/7157	4	EP300/SMAD2/SMAD3/TP53
BP	GO:0032869	cellular response to insulin stimulus	4/29	211/18614	0.000305155333947689	0.0048630240102426	0.00258482776990487	2885/5594/6714/7532	4	GRB2/MAPK1/SRC/YWHAG
BP	GO:0006474	N-terminal protein amino acid acetylation	2/29	17/18614	0.000314151519056918	0.0048630240102426	0.00258482776990487	1387/2033	2	CREBBP/EP300
BP	GO:0031053	primary miRNA processing	2/29	17/18614	0.000314151519056918	0.0048630240102426	0.00258482776990487	4087/4088	2	SMAD2/SMAD3
BP	GO:0090399	replicative senescence	2/29	17/18614	0.000314151519056918	0.0048630240102426	0.00258482776990487	1026/7157	2	CDKN1A/TP53
BP	GO:1900034	regulation of cellular response to heat	2/29	17/18614	0.000314151519056918	0.0048630240102426	0.00258482776990487	1387/2033	2	CREBBP/EP300
BP	GO:0061053	somite development	3/29	86/18614	0.000318985485820368	0.0048630240102426	0.00258482776990487	2033/4088/7157	3	EP300/SMAD3/TP53
BP	GO:1900182	positive regulation of protein localization to nucleus	3/29	86/18614	0.000318985485820368	0.0048630240102426	0.00258482776990487	2534/4088/6714	3	FYN/SMAD3/SRC
BP	GO:0048145	regulation of fibroblast proliferation	3/29	87/18614	0.000330032472474005	0.00498441565904666	0.00264935068901907	1026/2099/7157	3	CDKN1A/ESR1/TP53
BP	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	2/29	18/18614	0.000353079075101118	0.00514032239066132	0.00273221930092473	1026/7157	2	CDKN1A/TP53
BP	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	2/29	18/18614	0.000353079075101118	0.00514032239066132	0.00273221930092473	1026/7157	2	CDKN1A/TP53
BP	GO:0048339	paraxial mesoderm development	2/29	18/18614	0.000353079075101118	0.00514032239066132	0.00273221930092473	4087/4088	2	SMAD2/SMAD3
BP	GO:0071391	cellular response to estrogen stimulus	2/29	18/18614	0.000353079075101118	0.00514032239066132	0.00273221930092473	367/2099	2	AR/ESR1
BP	GO:0043254	regulation of protein-containing complex assembly	5/29	409/18614	0.000384099740525905	0.00553988186732189	0.00294459588570522	2033/2099/2885/6714/7157	5	EP300/ESR1/GRB2/SRC/TP53
BP	GO:0042772	DNA damage response, signal transduction resulting in transcription	2/29	19/18614	0.000394236642785902	0.00553988186732189	0.00294459588570522	1026/7157	2	CDKN1A/TP53
BP	GO:0060039	pericardium development	2/29	19/18614	0.000394236642785902	0.00553988186732189	0.00294459588570522	4087/4088	2	SMAD2/SMAD3
BP	GO:2000641	regulation of early endosome to late endosome transport	2/29	19/18614	0.000394236642785902	0.00553988186732189	0.00294459588570522	5594/6714	2	MAPK1/SRC
BP	GO:0097191	extrinsic apoptotic signaling pathway	4/29	227/18614	0.000402629608064915	0.00560904695373192	0.00298135898530826	367/9821/4088/6714	4	AR/RB1CC1/SMAD3/SRC
BP	GO:0006140	regulation of nucleotide metabolic process	3/29	94/18614	0.00041432346807231	0.00572262157610986	0.00304172694509226	978/2033/7157	3	CDA/EP300/TP53
BP	GO:0001558	regulation of cell growth	5/29	420/18614	0.000433699833726943	0.00589325116862456	0.00313242115268215	978/1026/1457/4088/7157	5	CDA/CDKN1A/CSNK2A1/SMAD3/TP53
BP	GO:0060749	mammary gland alveolus development	2/29	20/18614	0.000437617661036477	0.00589325116862456	0.00313242115268215	367/2099	2	AR/ESR1
BP	GO:0061377	mammary gland lobule development	2/29	20/18614	0.000437617661036477	0.00589325116862456	0.00313242115268215	367/2099	2	AR/ESR1
BP	GO:0003002	regionalization	5/29	422/18614	0.000443215863330656	0.00591931268712678	0.0031462735491763	367/2033/4087/4088/7157	5	AR/EP300/SMAD2/SMAD3/TP53
BP	GO:2000116	regulation of cysteine-type endopeptidase activity	4/29	234/18614	0.000451590918099475	0.00598172888236682	0.00317944943200321	1457/2534/4088/6714	4	CSNK2A1/FYN/SMAD3/SRC
BP	GO:0052547	regulation of peptidase activity	5/29	425/18614	0.000457785608800841	0.00601448409611511	0.00319685970715863	1457/2534/3065/4088/6714	5	CSNK2A1/FYN/HDAC1/SMAD3/SRC
BP	GO:0072593	reactive oxygen species metabolic process	4/29	237/18614	0.000473824191508269	0.00617499914094648	0.00328217776121178	1026/2534/2885/7157	4	CDKN1A/FYN/GRB2/TP53
BP	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	3/29	99/18614	0.000482284713367695	0.00623497677441756	0.00331405748301507	367/9821/6714	3	AR/RB1CC1/SRC
BP	GO:0035282	segmentation	3/29	100/18614	0.000496681198503976	0.00637013346652719	0.00338589689205718	2033/4088/7157	3	EP300/SMAD3/TP53
BP	GO:0006979	response to oxidative stress	5/29	434/18614	0.000503678143166535	0.00640900692407181	0.00340655917798502	2534/5594/4700/6714/7157	5	FYN/MAPK1/NDUFA6/SRC/TP53
BP	GO:0023019	signal transduction involved in regulation of gene expression	2/29	22/18614	0.000531023874016182	0.00663188924793162	0.00352502711458585	4087/4088	2	SMAD2/SMAD3
BP	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3/29	103/18614	0.000541518347234041	0.00663188924793162	0.00352502711458585	1026/2033/7157	3	CDKN1A/EP300/TP53
BP	GO:0010906	regulation of glucose metabolic process	3/29	103/18614	0.000541518347234041	0.00663188924793162	0.00352502711458585	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0048144	fibroblast proliferation	3/29	103/18614	0.000541518347234041	0.00663188924793162	0.00352502711458585	1026/2099/7157	3	CDKN1A/ESR1/TP53
BP	GO:0031349	positive regulation of defense response	5/29	441/18614	0.000541713725697384	0.00663188924793162	0.00352502711458585	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0048863	stem cell differentiation	4/29	247/18614	0.000553596849569698	0.00672640984138821	0.0035752673466472	2099/3065/5594/7157	4	ESR1/HDAC1/MAPK1/TP53
BP	GO:0060065	uterus development	2/29	23/18614	0.000581036015601612	0.0070071209045687	0.00372447281014074	2099/6714	2	ESR1/SRC
BP	GO:1901796	regulation of signal transduction by p53 class mediator	3/29	106/18614	0.000588872110169215	0.00704901725950704	0.00374674184715851	1984/2033/7157	3	EIF5A/EP300/TP53
BP	GO:0045926	negative regulation of growth	4/29	252/18614	0.000596877997545414	0.00709231502965727	0.00376975577397104	978/1026/4088/7157	4	CDA/CDKN1A/SMAD3/TP53
BP	GO:0062014	negative regulation of small molecule metabolic process	3/29	107/18614	0.000605225861353442	0.00709424300418001	0.00377078054417072	978/2033/7157	3	CDA/EP300/TP53
BP	GO:0009314	response to radiation	5/29	452/18614	0.000605820256545075	0.00709424300418001	0.00377078054417072	1026/1387/2033/2885/7157	5	CDKN1A/CREBBP/EP300/GRB2/TP53
BP	GO:0048568	embryonic organ development	5/29	453/18614	0.00061191945602621	0.00711411396358529	0.00378134249236946	2885/5594/4087/4088/7157	5	GRB2/MAPK1/SMAD2/SMAD3/TP53
BP	GO:0002831	regulation of response to biotic stimulus	5/29	463/18614	0.000675490434432585	0.00779708958602183	0.00414436236463902	1387/2033/2099/2534/6714	5	CREBBP/EP300/ESR1/FYN/SRC
BP	GO:0042659	regulation of cell fate specification	2/29	25/18614	0.000687645839241506	0.00782560335362165	0.00415951819733928	367/3065	2	AR/HDAC1
BP	GO:0045980	negative regulation of nucleotide metabolic process	2/29	25/18614	0.000687645839241506	0.00782560335362165	0.00415951819733928	978/7157	2	CDA/TP53
BP	GO:0007389	pattern specification process	5/29	467/18614	0.000702264002171036	0.00793607431824052	0.00421823647973181	367/2033/4087/4088/7157	5	AR/EP300/SMAD2/SMAD3/TP53
BP	GO:0071216	cellular response to biotic stimulus	4/29	264/18614	0.000710514241878467	0.00797354871441391	0.00423815512699437	978/5594/6714/7157	4	CDA/MAPK1/SRC/TP53
BP	GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	2/29	26/18614	0.000744230550558174	0.00812619303852709	0.0043192896817601	2534/6714	2	FYN/SRC
BP	GO:0033598	mammary gland epithelial cell proliferation	2/29	26/18614	0.000744230550558174	0.00812619303852709	0.0043192896817601	2099/5594	2	ESR1/MAPK1
BP	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	2/29	26/18614	0.000744230550558174	0.00812619303852709	0.0043192896817601	2534/6714	2	FYN/SRC
BP	GO:0060740	prostate gland epithelium morphogenesis	2/29	26/18614	0.000744230550558174	0.00812619303852709	0.0043192896817601	367/2099	2	AR/ESR1
BP	GO:0006476	protein deacetylation	3/29	116/18614	0.000765621823708998	0.00830365682626672	0.00441361644752061	2033/3065/7157	3	EP300/HDAC1/TP53
BP	GO:0051091	positive regulation of DNA-binding transcription factor activity	4/29	271/18614	0.000783473921396595	0.00844062571317932	0.00448641908673419	367/2033/2099/4088	4	AR/EP300/ESR1/SMAD3
BP	GO:0032868	response to insulin	4/29	272/18614	0.000794313537506703	0.00850073295768763	0.00451836770028211	2885/5594/6714/7532	4	GRB2/MAPK1/SRC/YWHAG
BP	GO:0045815	transcription initiation-coupled chromatin remodeling	2/29	27/18614	0.000802993170518288	0.00853708528656286	0.0045376899386629	2033/7157	2	EP300/TP53
BP	GO:0007611	learning or memory	4/29	276/18614	0.000838737324084555	0.0088588203641872	0.00470870076679048	2033/2534/5594/6714	4	EP300/FYN/MAPK1/SRC
BP	GO:0030325	adrenal gland development	2/29	28/18614	0.00086392724792229	0.00894940020924629	0.00475684638532111	4087/4088	2	SMAD2/SMAD3
BP	GO:0060512	prostate gland morphogenesis	2/29	28/18614	0.00086392724792229	0.00894940020924629	0.00475684638532111	367/2099	2	AR/ESR1
BP	GO:0060765	regulation of androgen receptor signaling pathway	2/29	28/18614	0.00086392724792229	0.00894940020924629	0.00475684638532111	2033/3065	2	EP300/HDAC1
BP	GO:0051348	negative regulation of transferase activity	4/29	279/18614	0.000873190097414728	0.00898774011096943	0.00477722507201085	1026/6714/7157/7532	4	CDKN1A/SRC/TP53/YWHAG
BP	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3/29	122/18614	0.000886252374943475	0.00906445467030795	0.00481800091907978	1387/2033/4087	3	CREBBP/EP300/SMAD2
BP	GO:0045165	cell fate commitment	4/29	281/18614	0.000896707822562081	0.00907923984141634	0.00482585963431197	367/3065/4087/7157	4	AR/HDAC1/SMAD2/TP53
BP	GO:0022612	gland morphogenesis	3/29	123/18614	0.000907460121842228	0.00907923984141634	0.00482585963431197	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0016049	cell growth	5/29	495/18614	0.000912673543096292	0.00907923984141634	0.00482585963431197	978/1026/1457/4088/7157	5	CDA/CDKN1A/CSNK2A1/SMAD3/TP53
BP	GO:0030878	thyroid gland development	2/29	29/18614	0.000927026345194119	0.00907923984141634	0.00482585963431197	5594/4088	2	MAPK1/SMAD3
BP	GO:0031571	mitotic G1 DNA damage checkpoint signaling	2/29	29/18614	0.000927026345194119	0.00907923984141634	0.00482585963431197	1026/7157	2	CDKN1A/TP53
BP	GO:0044819	mitotic G1/S transition checkpoint signaling	2/29	29/18614	0.000927026345194119	0.00907923984141634	0.00482585963431197	1026/7157	2	CDKN1A/TP53
BP	GO:1903649	regulation of cytoplasmic transport	2/29	29/18614	0.000927026345194119	0.00907923984141634	0.00482585963431197	5594/6714	2	MAPK1/SRC
BP	GO:0031365	N-terminal protein amino acid modification	2/29	30/18614	0.000992284038356709	0.00951922062954627	0.00505972123092089	1387/2033	2	CREBBP/EP300
BP	GO:0071480	cellular response to gamma radiation	2/29	30/18614	0.000992284038356709	0.00951922062954627	0.00505972123092089	1026/7157	2	CDKN1A/TP53
BP	GO:0001704	formation of primary germ layer	3/29	127/18614	0.000995512553461213	0.00951922062954627	0.00505972123092089	2885/4087/4088	3	GRB2/SMAD2/SMAD3
BP	GO:0035601	protein deacylation	3/29	127/18614	0.000995512553461213	0.00951922062954627	0.00505972123092089	2033/3065/7157	3	EP300/HDAC1/TP53
BP	GO:0034599	cellular response to oxidative stress	4/29	290/18614	0.0010081099505937	0.0095269338021019	0.00506382098913181	2534/5594/6714/7157	4	FYN/MAPK1/SRC/TP53
BP	GO:0044262	cellular carbohydrate metabolic process	4/29	290/18614	0.0010081099505937	0.0095269338021019	0.00506382098913181	2033/9821/6714/7157	4	EP300/RB1CC1/SRC/TP53
BP	GO:0008286	insulin receptor signaling pathway	3/29	128/18614	0.00101834055183751	0.00956766471958962	0.00508547056486786	2885/5594/6714	3	GRB2/MAPK1/SRC
BP	GO:0038127	ERBB signaling pathway	3/29	131/18614	0.00108881041554874	0.0101121702961308	0.00537488989163806	2885/5594/6714	3	GRB2/MAPK1/SRC
BP	GO:0098732	macromolecule deacylation	3/29	131/18614	0.00108881041554874	0.0101121702961308	0.00537488989163806	2033/3065/7157	3	EP300/HDAC1/TP53
BP	GO:0002431	Fc receptor mediated stimulatory signaling pathway	2/29	32/18614	0.00112924958429404	0.0103685643648816	0.0055111702199996	2534/6714	2	FYN/SRC
BP	GO:0002862	negative regulation of inflammatory response to antigenic stimulus	2/29	32/18614	0.00112924958429404	0.0103685643648816	0.0055111702199996	2534/6714	2	FYN/SRC
BP	GO:0048565	digestive tract development	3/29	134/18614	0.00116229805164166	0.0105520991654658	0.00560872389201414	4087/4088/6714	3	SMAD2/SMAD3/SRC
BP	GO:1900180	regulation of protein localization to nucleus	3/29	134/18614	0.00116229805164166	0.0105520991654658	0.00560872389201414	2534/4088/6714	3	FYN/SMAD3/SRC
BP	GO:0038094	Fc-gamma receptor signaling pathway	2/29	33/18614	0.00120094465688953	0.0108420478521423	0.00576283940030493	2534/6714	2	FYN/SRC
BP	GO:0046651	lymphocyte proliferation	4/29	306/18614	0.00122972807237571	0.0110402253608842	0.00586817606467006	11119/1026/2534/7157	4	BTN3A1/CDKN1A/FYN/TP53
BP	GO:0035270	endocrine system development	3/29	137/18614	0.00123885289363082	0.011060697658052	0.00587905764002764	5594/4087/4088	3	MAPK1/SMAD2/SMAD3
BP	GO:0071375	cellular response to peptide hormone stimulus	4/29	308/18614	0.00125964669990025	0.01113531236859	0.00591871736110567	2885/5594/6714/7532	4	GRB2/MAPK1/SRC/YWHAG
BP	GO:0009112	nucleobase metabolic process	2/29	34/18614	0.00127477276496853	0.01113531236859	0.00591871736110567	978/5594	2	CDA/MAPK1
BP	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	2/29	34/18614	0.00127477276496853	0.01113531236859	0.00591871736110567	1387/2033	2	CREBBP/EP300
BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	2/29	34/18614	0.00127477276496853	0.01113531236859	0.00591871736110567	1387/2033	2	CREBBP/EP300
BP	GO:0050852	T cell receptor signaling pathway	3/29	140/18614	0.00131852357692072	0.0114555596790531	0.00608893740106003	11119/2534/5594	3	BTN3A1/FYN/MAPK1
BP	GO:0032943	mononuclear cell proliferation	4/29	313/18614	0.0013366768280386	0.0115490779064927	0.00613864484868296	11119/1026/2534/7157	4	BTN3A1/CDKN1A/FYN/TP53
BP	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	2/29	35/18614	0.00135072755218263	0.0115490779064927	0.00613864484868296	367/6714	2	AR/SRC
BP	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	2/29	35/18614	0.00135072755218263	0.0115490779064927	0.00613864484868296	1984/7157	2	EIF5A/TP53
BP	GO:0050890	cognition	4/29	317/18614	0.00140063703498856	0.0118565153944274	0.00630205612418757	2033/2534/5594/6714	4	EP300/FYN/MAPK1/SRC
BP	GO:0010212	response to ionizing radiation	3/29	143/18614	0.00140135794575225	0.0118565153944274	0.00630205612418757	1026/2885/7157	3	CDKN1A/GRB2/TP53
BP	GO:0035264	multicellular organism growth	3/29	145/18614	0.00145836173294732	0.0122745445856399	0.00652424985792222	367/2033/7157	3	AR/EP300/TP53
BP	GO:0030177	positive regulation of Wnt signaling pathway	3/29	146/18614	0.00148740306010268	0.0123899141501337	0.00658557187761145	1457/4088/6714	3	CSNK2A1/SMAD3/SRC
BP	GO:0055123	digestive system development	3/29	146/18614	0.00148740306010268	0.0123899141501337	0.00658557187761145	4087/4088/6714	3	SMAD2/SMAD3/SRC
BP	GO:0009416	response to light stimulus	4/29	323/18614	0.00150055881646081	0.0124354002430803	0.00660974895671805	1026/1387/2033/7157	4	CDKN1A/CREBBP/EP300/TP53
BP	GO:0051053	negative regulation of DNA metabolic process	3/29	148/18614	0.00154657310455532	0.0127513374334765	0.00677767805218659	1026/6714/7157	3	CDKN1A/SRC/TP53
BP	GO:0071496	cellular response to external stimulus	4/29	327/18614	0.00156988233011356	0.0128778164744341	0.00684490505676016	978/1026/5594/7157	4	CDA/CDKN1A/MAPK1/TP53
BP	GO:0062012	regulation of small molecule metabolic process	4/29	331/18614	0.00164141672778612	0.013354479080212	0.00709826402387507	978/2033/6714/7157	4	CDA/EP300/SRC/TP53
BP	GO:0032386	regulation of intracellular transport	4/29	332/18614	0.00165965016107998	0.013354479080212	0.00709826402387507	2534/5594/4088/6714	4	FYN/MAPK1/SMAD3/SRC
BP	GO:0051604	protein maturation	4/29	332/18614	0.00165965016107998	0.013354479080212	0.00709826402387507	552900/1387/2033/6714	4	BOLA2/CREBBP/EP300/SRC
BP	GO:0010675	regulation of cellular carbohydrate metabolic process	3/29	152/18614	0.0016693098850265	0.013354479080212	0.00709826402387507	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0034614	cellular response to reactive oxygen species	3/29	152/18614	0.0016693098850265	0.013354479080212	0.00709826402387507	2534/5594/6714	3	FYN/MAPK1/SRC
BP	GO:0007265	Ras protein signal transduction	4/29	333/18614	0.00167802469573887	0.0133580685138621	0.00710017190418934	1026/2885/6714/7157	4	CDKN1A/GRB2/SRC/TP53
BP	GO:0060562	epithelial tube morphogenesis	4/29	334/18614	0.00169654091527396	0.0134392652896212	0.00714333016957456	367/2099/4088/6714	4	AR/ESR1/SMAD3/SRC
BP	GO:0009895	negative regulation of catabolic process	4/29	337/18614	0.0017529455146351	0.0138183412275626	0.00734481920381127	1457/2534/4088/7157	4	CSNK2A1/FYN/SMAD3/TP53
BP	GO:0030111	regulation of Wnt signaling pathway	4/29	338/18614	0.00177203430391889	0.0139010069666647	0.00738875826263574	1457/3065/4088/6714	4	CSNK2A1/HDAC1/SMAD3/SRC
BP	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3/29	156/18614	0.00179799731278958	0.0140365394080578	0.00746079739250598	367/9821/6714	3	AR/RB1CC1/SRC
BP	GO:0048754	branching morphogenesis of an epithelial tube	3/29	157/18614	0.0018311111955764	0.0142263254425551	0.00756167376310903	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0098751	bone cell development	2/29	41/18614	0.00185076227378818	0.0143102001647928	0.00760625542891542	2033/6714	2	EP300/SRC
BP	GO:0010453	regulation of cell fate commitment	2/29	42/18614	0.00194142696417404	0.0149397427338345	0.00794087419932839	367/3065	2	AR/HDAC1
BP	GO:0062197	cellular response to chemical stress	4/29	349/18614	0.00199168239160911	0.0152538329139352	0.00810782155925685	2534/5594/6714/7157	4	FYN/MAPK1/SRC/TP53
BP	GO:0016052	carbohydrate catabolic process	3/29	162/18614	0.00200241272460926	0.0152636743536253	0.00811305254856584	2033/9821/7157	3	EP300/RB1CC1/TP53
BP	GO:0006606	protein import into nucleus	3/29	163/18614	0.00203783047106487	0.0154607231983138	0.00821778929769673	1026/4088/7157	3	CDKN1A/SMAD3/TP53
BP	GO:0032924	activin receptor signaling pathway	2/29	44/18614	0.00212897904064993	0.0159279172670847	0.00846611548328628	4087/4088	2	SMAD2/SMAD3
BP	GO:0044275	cellular carbohydrate catabolic process	2/29	44/18614	0.00212897904064993	0.0159279172670847	0.00846611548328628	9821/7157	2	RB1CC1/TP53
BP	GO:0045022	early endosome to late endosome transport	2/29	44/18614	0.00212897904064993	0.0159279172670847	0.00846611548328628	5594/6714	2	MAPK1/SRC
BP	GO:0051170	import into nucleus	3/29	168/18614	0.00222079147276464	0.0164245662638691	0.00873009775359381	1026/4088/7157	3	CDKN1A/SMAD3/TP53
BP	GO:0031295	T cell costimulation	2/29	45/18614	0.00222585396769019	0.0164245662638691	0.00873009775359381	2534/6714	2	FYN/SRC
BP	GO:0048701	embryonic cranial skeleton morphogenesis	2/29	45/18614	0.00222585396769019	0.0164245662638691	0.00873009775359381	4087/4088	2	SMAD2/SMAD3
BP	GO:0009267	cellular response to starvation	3/29	170/18614	0.00229674458950363	0.0168706329847176	0.00896719418677014	1026/5594/7157	3	CDKN1A/MAPK1/TP53
BP	GO:0002861	regulation of inflammatory response to antigenic stimulus	2/29	47/18614	0.00242577055087778	0.0174224231565266	0.00926048547142115	2534/6714	2	FYN/SRC
BP	GO:0031294	lymphocyte costimulation	2/29	47/18614	0.00242577055087778	0.0174224231565266	0.00926048547142115	2534/6714	2	FYN/SRC
BP	GO:0048806	genitalia development	2/29	47/18614	0.00242577055087778	0.0174224231565266	0.00926048547142115	367/2099	2	AR/ESR1
BP	GO:0060711	labyrinthine layer development	2/29	47/18614	0.00242577055087778	0.0174224231565266	0.00926048547142115	2885/5594	2	GRB2/MAPK1
BP	GO:0098927	vesicle-mediated transport between endosomal compartments	2/29	47/18614	0.00242577055087778	0.0174224231565266	0.00926048547142115	5594/6714	2	MAPK1/SRC
BP	GO:0030850	prostate gland development	2/29	48/18614	0.00252879982717674	0.0179620613989	0.00954731767945699	367/2099	2	AR/ESR1
BP	GO:0050798	activated T cell proliferation	2/29	48/18614	0.00252879982717674	0.0179620613989	0.00954731767945699	11119/2534	2	BTN3A1/FYN
BP	GO:0048660	regulation of smooth muscle cell proliferation	3/29	176/18614	0.00253425123697351	0.0179620613989	0.00954731767945699	1026/3065/6714	3	CDKN1A/HDAC1/SRC
BP	GO:0034198	cellular response to amino acid starvation	2/29	49/18614	0.00263386819529726	0.0185865982689973	0.00987927578654363	1026/5594	2	CDKN1A/MAPK1
BP	GO:0035265	organ growth	3/29	180/18614	0.00270074430560267	0.0188935186054282	0.0100424121821453	367/2099/4087	3	AR/ESR1/SMAD2
BP	GO:0048659	smooth muscle cell proliferation	3/29	180/18614	0.00270074430560267	0.0188935186054282	0.0100424121821453	1026/3065/6714	3	CDKN1A/HDAC1/SRC
BP	GO:0048546	digestive tract morphogenesis	2/29	50/18614	0.00274096949815512	0.0189458735361505	0.0100702402328679	4087/4088	2	SMAD2/SMAD3
BP	GO:2000378	negative regulation of reactive oxygen species metabolic process	2/29	50/18614	0.00274096949815512	0.0189458735361505	0.0100702402328679	2534/7157	2	FYN/TP53
BP	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3/29	181/18614	0.00274340000461585	0.0189458735361505	0.0100702402328679	2534/6714/7157	3	FYN/SRC/TP53
BP	GO:0006109	regulation of carbohydrate metabolic process	3/29	183/18614	0.00282996006574759	0.0192709527543229	0.0102430285614431	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0019083	viral transcription	2/29	51/18614	0.00285009759175938	0.0192709527543229	0.0102430285614431	2033/3065	2	EP300/HDAC1
BP	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	2/29	51/18614	0.00285009759175938	0.0192709527543229	0.0102430285614431	2099/3065	2	ESR1/HDAC1
BP	GO:0045912	negative regulation of carbohydrate metabolic process	2/29	51/18614	0.00285009759175938	0.0192709527543229	0.0102430285614431	2033/7157	2	EP300/TP53
BP	GO:0060688	regulation of morphogenesis of a branching structure	2/29	51/18614	0.00285009759175938	0.0192709527543229	0.0102430285614431	367/2099	2	AR/ESR1
BP	GO:0042770	signal transduction in response to DNA damage	3/29	184/18614	0.00287386717780035	0.0193507056638557	0.0102854193731802	1026/2885/7157	3	CDKN1A/GRB2/TP53
BP	GO:0022602	ovulation cycle process	2/29	52/18614	0.00296124634518876	0.0195433260376497	0.0103878022711843	2099/6714	2	ESR1/SRC
BP	GO:0048013	ephrin receptor signaling pathway	2/29	52/18614	0.00296124634518876	0.0195433260376497	0.0103878022711843	2534/6714	2	FYN/SRC
BP	GO:0060324	face development	2/29	52/18614	0.00296124634518876	0.0195433260376497	0.0103878022711843	2033/5594	2	EP300/MAPK1
BP	GO:1990928	response to amino acid starvation	2/29	52/18614	0.00296124634518876	0.0195433260376497	0.0103878022711843	1026/5594	2	CDKN1A/MAPK1
BP	GO:0030324	lung development	3/29	186/18614	0.00296294237575754	0.0195433260376497	0.0103878022711843	2033/5594/4087	3	EP300/MAPK1/SMAD2
BP	GO:0006006	glucose metabolic process	3/29	187/18614	0.00300811316053778	0.0196806107993079	0.0104607728063023	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0050728	negative regulation of inflammatory response	3/29	187/18614	0.00300811316053778	0.0196806107993079	0.0104607728063023	2534/4088/6714	3	FYN/SMAD3/SRC
BP	GO:0040029	epigenetic regulation of gene expression	3/29	188/18614	0.00305370785434303	0.0198729839166316	0.0105630242808568	2033/3065/7157	3	EP300/HDAC1/TP53
BP	GO:0032210	regulation of telomere maintenance via telomerase	2/29	53/18614	0.00307440964056801	0.0198729839166316	0.0105630242808568	5594/6714	2	MAPK1/SRC
BP	GO:0048146	positive regulation of fibroblast proliferation	2/29	53/18614	0.00307440964056801	0.0198729839166316	0.0105630242808568	1026/2099	2	CDKN1A/ESR1
BP	GO:0030323	respiratory tube development	3/29	190/18614	0.00314617427397835	0.020255847118522	0.0107665263475208	2033/5594/4087	3	EP300/MAPK1/SMAD2
BP	GO:0038093	Fc receptor signaling pathway	2/29	54/18614	0.00318958137304431	0.0204538234080937	0.0108717560584969	2534/6714	2	FYN/SRC
BP	GO:0006338	chromatin remodeling	4/29	402/18614	0.00331965756558706	0.0212038206560818	0.0112703997233994	2033/2099/3065/7157	4	EP300/ESR1/HDAC1/TP53
BP	GO:0002520	immune system development	3/29	197/18614	0.0034833524215575	0.0221316275074228	0.0117635539643415	5594/4088/7157	3	MAPK1/SMAD3/TP53
BP	GO:0001541	ovarian follicle development	2/29	57/18614	0.00354708633937037	0.0221316275074228	0.0117635539643415	2099/6714	2	ESR1/SRC
BP	GO:0001706	endoderm formation	2/29	57/18614	0.00354708633937037	0.0221316275074228	0.0117635539643415	2885/4087	2	GRB2/SMAD2
BP	GO:0010332	response to gamma radiation	2/29	57/18614	0.00354708633937037	0.0221316275074228	0.0117635539643415	1026/7157	2	CDKN1A/TP53
BP	GO:0043470	regulation of carbohydrate catabolic process	2/29	57/18614	0.00354708633937037	0.0221316275074228	0.0117635539643415	2033/7157	2	EP300/TP53
BP	GO:0072132	mesenchyme morphogenesis	2/29	57/18614	0.00354708633937037	0.0221316275074228	0.0117635539643415	4087/4088	2	SMAD2/SMAD3
BP	GO:0010718	positive regulation of epithelial to mesenchymal transition	2/29	58/18614	0.00367023103133296	0.0224894690728764	0.0119537563597363	4087/4088	2	SMAD2/SMAD3
BP	GO:0042733	embryonic digit morphogenesis	2/29	58/18614	0.00367023103133296	0.0224894690728764	0.0119537563597363	1387/3065	2	CREBBP/HDAC1
BP	GO:0048010	vascular endothelial growth factor receptor signaling pathway	2/29	58/18614	0.00367023103133296	0.0224894690728764	0.0119537563597363	2534/6714	2	FYN/SRC
BP	GO:0090311	regulation of protein deacetylation	2/29	58/18614	0.00367023103133296	0.0224894690728764	0.0119537563597363	2033/7157	2	EP300/TP53
BP	GO:0043393	regulation of protein binding	3/29	201/18614	0.00368560760486957	0.0224894690728764	0.0119537563597363	1026/2033/6714	3	CDKN1A/EP300/SRC
BP	GO:0050727	regulation of inflammatory response	4/29	414/18614	0.0036879389259358	0.0224894690728764	0.0119537563597363	2099/2534/4088/6714	4	ESR1/FYN/SMAD3/SRC
BP	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3/29	204/18614	0.00384193303274189	0.0233404653417703	0.0124060837147502	1457/4088/6714	3	CSNK2A1/SMAD3/SRC
BP	GO:0000302	response to reactive oxygen species	3/29	205/18614	0.00389493064226488	0.0235738124265919	0.012530113952644	2534/5594/6714	3	FYN/MAPK1/SRC
BP	GO:0007623	circadian rhythm	3/29	207/18614	0.00400226670788235	0.024012739008538	0.0127634152103745	2033/3065/7157	3	EP300/HDAC1/TP53
BP	GO:0042594	response to starvation	3/29	207/18614	0.00400226670788235	0.024012739008538	0.0127634152103745	1026/5594/7157	3	CDKN1A/MAPK1/TP53
BP	GO:0035306	positive regulation of dephosphorylation	2/29	61/18614	0.00405150965531918	0.024012739008538	0.0127634152103745	4088/6714	2	SMAD3/SRC
BP	GO:0060135	maternal process involved in female pregnancy	2/29	61/18614	0.00405150965531918	0.024012739008538	0.0127634152103745	367/2099	2	AR/ESR1
BP	GO:1904356	regulation of telomere maintenance via telomere lengthening	2/29	61/18614	0.00405150965531918	0.024012739008538	0.0127634152103745	5594/6714	2	MAPK1/SRC
BP	GO:1901654	response to ketone	3/29	208/18614	0.00405660751815029	0.024012739008538	0.0127634152103745	367/978/6714	3	AR/CDA/SRC
BP	GO:0043434	response to peptide hormone	4/29	427/18614	0.00411741957263493	0.0242837592313068	0.0129074697321172	2885/5594/6714/7532	4	GRB2/MAPK1/SRC/YWHAG
BP	GO:0002064	epithelial cell development	3/29	210/18614	0.0041666405195795	0.0244846948350563	0.0130142723979976	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0060261	positive regulation of transcription initiation by RNA polymerase II	2/29	62/18614	0.00418253066481558	0.0244890201244274	0.0130165714053757	2099/7157	2	ESR1/TP53
BP	GO:0060541	respiratory system development	3/29	211/18614	0.00422233501744919	0.0246328281162379	0.0130930092123828	2033/5594/4087	3	EP300/MAPK1/SMAD2
BP	GO:0034470	ncRNA processing	4/29	432/18614	0.00429129600080485	0.0249305997011231	0.0132512828010139	23536/4087/4088/7157	4	ADAT1/SMAD2/SMAD3/TP53
BP	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	2/29	63/18614	0.00431550574987298	0.0249305997011231	0.0132512828010139	1984/7157	2	EIF5A/TP53
BP	GO:0042098	T cell proliferation	3/29	213/18614	0.00433508571535619	0.0249305997011231	0.0132512828010139	11119/2534/7157	3	BTN3A1/FYN/TP53
BP	GO:0050821	protein stabilization	3/29	213/18614	0.00433508571535619	0.0249305997011231	0.0132512828010139	2033/4088/7157	3	EP300/SMAD3/TP53
BP	GO:0051893	regulation of focal adhesion assembly	2/29	64/18614	0.0044504289345748	0.0254130500292328	0.0135077180978725	4088/6714	2	SMAD3/SRC
BP	GO:0090109	regulation of cell-substrate junction assembly	2/29	64/18614	0.0044504289345748	0.0254130500292328	0.0135077180978725	4088/6714	2	SMAD3/SRC
BP	GO:0042060	wound healing	4/29	439/18614	0.00454302156248971	0.0257597292806434	0.0136919874237917	1026/4087/4088/6714	4	CDKN1A/SMAD2/SMAD3/SRC
BP	GO:0045936	negative regulation of phosphate metabolic process	4/29	439/18614	0.00454302156248971	0.0257597292806434	0.0136919874237917	978/1026/7157/7532	4	CDA/CDKN1A/TP53/YWHAG
BP	GO:0010563	negative regulation of phosphorus metabolic process	4/29	440/18614	0.00457978183974249	0.0258295035446843	0.013729074317654	978/1026/7157/7532	4	CDA/CDKN1A/TP53/YWHAG
BP	GO:1905330	regulation of morphogenesis of an epithelium	2/29	65/18614	0.00458729425577004	0.0258295035446843	0.013729074317654	367/2099	2	AR/ESR1
BP	GO:0001655	urogenital system development	2/29	66/18614	0.00472609576305027	0.0265186484482265	0.0140953733283955	367/2099	2	AR/ESR1
BP	GO:0034605	cellular response to heat	2/29	67/18614	0.00486682751872638	0.0272138175441586	0.0144648743590629	1387/2033	2	CREBBP/EP300
BP	GO:0048645	animal organ formation	2/29	68/18614	0.00500948359780568	0.0277237174453903	0.0147358998406973	367/5594	2	AR/MAPK1
BP	GO:0051123	RNA polymerase II preinitiation complex assembly	2/29	68/18614	0.00500948359780568	0.0277237174453903	0.0147358998406973	2099/7157	2	ESR1/TP53
BP	GO:2000144	positive regulation of DNA-templated transcription initiation	2/29	68/18614	0.00500948359780568	0.0277237174453903	0.0147358998406973	2099/7157	2	ESR1/TP53
BP	GO:0007004	telomere maintenance via telomerase	2/29	69/18614	0.00515405808796885	0.0283297886740057	0.0150580429637758	5594/6714	2	MAPK1/SRC
BP	GO:0150116	regulation of cell-substrate junction organization	2/29	69/18614	0.00515405808796885	0.0283297886740057	0.0150580429637758	4088/6714	2	SMAD3/SRC
BP	GO:0046777	protein autophosphorylation	3/29	227/18614	0.0051758786075943	0.0283532875588894	0.0150705332517286	2534/9821/6714	3	FYN/RB1CC1/SRC
BP	GO:0008406	gonad development	3/29	228/18614	0.0052394319332268	0.0285081548959411	0.0151528493975299	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0019318	hexose metabolic process	3/29	228/18614	0.0052394319332268	0.0285081548959411	0.0151528493975299	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0009880	embryonic pattern specification	2/29	70/18614	0.00530054508954696	0.028743895519154	0.0152781518653137	4087/4088	2	SMAD2/SMAD3
BP	GO:0031669	cellular response to nutrient levels	3/29	230/18614	0.00536795484329281	0.0290120903905056	0.0154207046369545	1026/5594/7157	3	CDKN1A/MAPK1/TP53
BP	GO:0016055	Wnt signaling pathway	4/29	461/18614	0.0053990798750376	0.0290830435935359	0.0154584181685287	1457/3065/4088/6714	4	CSNK2A1/HDAC1/SMAD3/SRC
BP	GO:0198738	cell-cell signaling by wnt	4/29	463/18614	0.00548191551551959	0.0294311477510952	0.0156434448703059	1457/3065/4088/6714	4	CSNK2A1/HDAC1/SMAD3/SRC
BP	GO:0045137	development of primary sexual characteristics	3/29	233/18614	0.00556429480945652	0.0295698061296752	0.0157171455196814	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0051090	regulation of DNA-binding transcription factor activity	4/29	465/18614	0.00556560413203761	0.0295698061296752	0.0157171455196814	367/2033/2099/4088	4	AR/EP300/ESR1/SMAD3
BP	GO:0030330	DNA damage response, signal transduction by p53 class mediator	2/29	72/18614	0.00559923309138652	0.0295698061296752	0.0157171455196814	1026/7157	2	CDKN1A/TP53
BP	GO:0060260	regulation of transcription initiation by RNA polymerase II	2/29	72/18614	0.00559923309138652	0.0295698061296752	0.0157171455196814	2099/7157	2	ESR1/TP53
BP	GO:1904888	cranial skeletal system development	2/29	72/18614	0.00559923309138652	0.0295698061296752	0.0157171455196814	4087/4088	2	SMAD2/SMAD3
BP	GO:0060348	bone development	3/29	235/18614	0.00569756998003352	0.0298937437913447	0.0158893270803396	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0071356	cellular response to tumor necrosis factor	3/29	235/18614	0.00569756998003352	0.0298937437913447	0.0158893270803396	1984/5594/7157	3	EIF5A/MAPK1/TP53
BP	GO:0051403	stress-activated MAPK cascade	3/29	237/18614	0.00583275965202751	0.0305040116429659	0.01621370082117	5594/9821/4088	3	MAPK1/RB1CC1/SMAD3
BP	GO:2000573	positive regulation of DNA biosynthetic process	2/29	74/18614	0.00590550065810998	0.0307848034306636	0.0163629491919108	5594/6714	2	MAPK1/SRC
BP	GO:0016570	histone modification	4/29	475/18614	0.00599698183640452	0.0311611660695489	0.0165629960348827	1387/2033/3065/7157	4	CREBBP/EP300/HDAC1/TP53
BP	GO:0001707	mesoderm formation	2/29	75/18614	0.00606146216288877	0.0311952957172874	0.0165811368585895	4087/4088	2	SMAD2/SMAD3
BP	GO:0006278	RNA-templated DNA biosynthetic process	2/29	75/18614	0.00606146216288877	0.0311952957172874	0.0165811368585895	5594/6714	2	MAPK1/SRC
BP	GO:0042698	ovulation cycle	2/29	75/18614	0.00606146216288877	0.0311952957172874	0.0165811368585895	2099/6714	2	ESR1/SRC
BP	GO:0031667	response to nutrient levels	4/29	477/18614	0.00608587208689453	0.0312214898172113	0.0165950597256673	1026/5594/6714/7157	4	CDKN1A/MAPK1/SRC/TP53
BP	GO:0007264	small GTPase mediated signal transduction	4/29	483/18614	0.00635784301650036	0.0323849111626474	0.0172134493933821	1026/2885/6714/7157	4	CDKN1A/GRB2/SRC/TP53
BP	GO:0048332	mesoderm morphogenesis	2/29	77/18614	0.00637901149402312	0.0323849111626474	0.0172134493933821	4087/4088	2	SMAD2/SMAD3
BP	GO:0050853	B cell receptor signaling pathway	2/29	77/18614	0.00637901149402312	0.0323849111626474	0.0172134493933821	2885/5594	2	GRB2/MAPK1
BP	GO:0031098	stress-activated protein kinase signaling cascade	3/29	245/18614	0.00639281352777507	0.0323849111626474	0.0172134493933821	5594/9821/4088	3	MAPK1/RB1CC1/SMAD3
BP	GO:0002437	inflammatory response to antigenic stimulus	2/29	78/18614	0.006540587709334	0.0328399940069405	0.0174553381381341	2534/6714	2	FYN/SRC
BP	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	2/29	78/18614	0.006540587709334	0.0328399940069405	0.0174553381381341	1457/6714	2	CSNK2A1/SRC
BP	GO:0050804	modulation of chemical synaptic transmission	4/29	487/18614	0.00654361266722454	0.0328399940069405	0.0174553381381341	2534/5594/6714/7532	4	FYN/MAPK1/SRC/YWHAG
BP	GO:0050673	epithelial cell proliferation	4/29	488/18614	0.0065906164679878	0.0328717167045318	0.0174721996032425	367/2099/5594/4088	4	AR/ESR1/MAPK1/SMAD3
BP	GO:0099177	regulation of trans-synaptic signaling	4/29	488/18614	0.0065906164679878	0.0328717167045318	0.0174721996032425	2534/5594/6714/7532	4	FYN/MAPK1/SRC/YWHAG
BP	GO:0033002	muscle cell proliferation	3/29	249/18614	0.00668451949417549	0.0332374877002695	0.0176666167036347	1026/3065/6714	3	CDKN1A/HDAC1/SRC
BP	GO:0033044	regulation of chromosome organization	3/29	250/18614	0.00675867212158771	0.0335031108849256	0.0178078025547807	246184/5594/6714	3	CDC26/MAPK1/SRC
BP	GO:2000142	regulation of DNA-templated transcription initiation	2/29	80/18614	0.00686931430520547	0.0339474370556943	0.0180439738388787	2099/7157	2	ESR1/TP53
BP	GO:0097305	response to alcohol	3/29	252/18614	0.00690845473945759	0.034036777009035	0.0180914604216861	978/2534/4087	3	CDA/FYN/SMAD2
BP	GO:0010833	telomere maintenance via telomere lengthening	2/29	81/18614	0.00703645314932556	0.0344572978463943	0.0183149785322158	5594/6714	2	MAPK1/SRC
BP	GO:0044773	mitotic DNA damage checkpoint signaling	2/29	81/18614	0.00703645314932556	0.0344572978463943	0.0183149785322158	1026/7157	2	CDKN1A/TP53
BP	GO:0048762	mesenchymal cell differentiation	3/29	255/18614	0.00713683467152362	0.0347383277987415	0.0184643534938595	5594/4087/4088	3	MAPK1/SMAD2/SMAD3
BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	3/29	255/18614	0.00713683467152362	0.0347383277987415	0.0184643534938595	2534/6714/7157	3	FYN/SRC/TP53
BP	GO:0005996	monosaccharide metabolic process	3/29	256/18614	0.00721395289485825	0.035008251886159	0.018607825390246	2033/6714/7157	3	EP300/SRC/TP53
BP	GO:0034612	response to tumor necrosis factor	3/29	257/18614	0.00729156826758159	0.0352663465728582	0.0187450096426865	1984/5594/7157	3	EIF5A/MAPK1/TP53
BP	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	3/29	258/18614	0.00736968159532419	0.0352663465728582	0.0187450096426865	2099/2534/3065	3	ESR1/FYN/HDAC1
BP	GO:0051851	modulation by host of symbiont process	2/29	83/18614	0.0073762531816993	0.0352663465728582	0.0187450096426865	2033/3065	2	EP300/HDAC1
BP	GO:0070897	transcription preinitiation complex assembly	2/29	83/18614	0.0073762531816993	0.0352663465728582	0.0187450096426865	2099/7157	2	ESR1/TP53
BP	GO:0072527	pyrimidine-containing compound metabolic process	2/29	83/18614	0.0073762531816993	0.0352663465728582	0.0187450096426865	978/5594	2	CDA/MAPK1
BP	GO:0060828	regulation of canonical Wnt signaling pathway	3/29	260/18614	0.00752740530453319	0.0358794914672373	0.0190709126089537	3065/4088/6714	3	HDAC1/SMAD3/SRC
BP	GO:0061515	myeloid cell development	2/29	84/18614	0.00754890290771082	0.0358794914672373	0.0190709126089537	2033/6714	2	EP300/SRC
BP	GO:0031668	cellular response to extracellular stimulus	3/29	261/18614	0.00760701726346913	0.0360496771195487	0.0191613708504115	1026/5594/7157	3	CDKN1A/MAPK1/TP53
BP	GO:0003007	heart morphogenesis	3/29	262/18614	0.00768713033240664	0.0362819159728799	0.0192848120335266	4087/4088/7157	3	SMAD2/SMAD3/TP53
BP	GO:0044774	mitotic DNA integrity checkpoint signaling	2/29	85/18614	0.00772337815264275	0.0362819159728799	0.0192848120335266	1026/7157	2	CDKN1A/TP53
BP	GO:0098586	cellular response to virus	2/29	85/18614	0.00772337815264275	0.0362819159728799	0.0192848120335266	1984/4088	2	EIF5A/SMAD3
BP	GO:0034103	regulation of tissue remodeling	2/29	86/18614	0.00789967321613853	0.0367892562457633	0.0195544770040013	6714/7157	2	SRC/TP53
BP	GO:0048041	focal adhesion assembly	2/29	86/18614	0.00789967321613853	0.0367892562457633	0.0195544770040013	4088/6714	2	SMAD3/SRC
BP	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	2/29	86/18614	0.00789967321613853	0.0367892562457633	0.0195544770040013	1026/7157	2	CDKN1A/TP53
BP	GO:0097194	execution phase of apoptosis	2/29	87/18614	0.00807778241010712	0.0374031414748799	0.0198807734780498	662/7157	2	BNIP1/TP53
BP	GO:2000243	positive regulation of reproductive process	2/29	87/18614	0.00807778241010712	0.0374031414748799	0.0198807734780498	367/6714	2	AR/SRC
BP	GO:0001892	embryonic placenta development	2/29	89/18614	0.00843942049829245	0.038966010072116	0.02071148008002	2885/5594	2	GRB2/MAPK1
BP	GO:0060395	SMAD protein signal transduction	2/29	90/18614	0.00862293807745424	0.0396999086414987	0.0211015668652052	4087/4088	2	SMAD2/SMAD3
BP	GO:2000117	negative regulation of cysteine-type endopeptidase activity	2/29	91/18614	0.00880824715693449	0.0404378619477447	0.0214938088518497	1457/6714	2	CSNK2A1/SRC
BP	GO:0042113	B cell activation	3/29	276/18614	0.00886175010702755	0.0405682384503018	0.0215631074618592	1026/2033/7157	3	CDKN1A/EP300/TP53
BP	GO:0000422	autophagy of mitochondrion	2/29	92/18614	0.00899534210963601	0.040832788902168	0.0217037231267386	9821/7157	2	RB1CC1/TP53
BP	GO:0061726	mitochondrion disassembly	2/29	92/18614	0.00899534210963601	0.040832788902168	0.0217037231267386	9821/7157	2	RB1CC1/TP53
BP	GO:1901216	positive regulation of neuron death	2/29	92/18614	0.00899534210963601	0.040832788902168	0.0217037231267386	2534/7157	2	FYN/TP53
BP	GO:0061912	selective autophagy	2/29	93/18614	0.00918421732059375	0.0413417693316978	0.0219742598844876	9821/7157	2	RB1CC1/TP53
BP	GO:0070301	cellular response to hydrogen peroxide	2/29	93/18614	0.00918421732059375	0.0413417693316978	0.0219742598844876	2534/6714	2	FYN/SRC
BP	GO:1900542	regulation of purine nucleotide metabolic process	2/29	93/18614	0.00918421732059375	0.0413417693316978	0.0219742598844876	2033/7157	2	EP300/TP53
BP	GO:0016575	histone deacetylation	2/29	94/18614	0.00937486718695293	0.042082737150322	0.0223681041653614	3065/7157	2	HDAC1/TP53
BP	GO:0007548	sex differentiation	3/29	283/18614	0.00948657001463499	0.0424661970738231	0.0225719234055756	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0048704	embryonic skeletal system morphogenesis	2/29	95/18614	0.00956728611794674	0.0425216268214438	0.0226013858039983	4087/4088	2	SMAD2/SMAD3
BP	GO:1904705	regulation of vascular associated smooth muscle cell proliferation	2/29	95/18614	0.00956728611794674	0.0425216268214438	0.0226013858039983	1026/6714	2	CDKN1A/SRC
BP	GO:0031348	negative regulation of defense response	3/29	284/18614	0.00957789118997867	0.0425216268214438	0.0226013858039983	2534/4088/6714	3	FYN/SMAD3/SRC
BP	GO:0007044	cell-substrate junction assembly	2/29	96/18614	0.00976146853487455	0.0430998173561674	0.0229087095900421	4088/6714	2	SMAD3/SRC
BP	GO:0048534	hematopoietic or lymphoid organ development	2/29	96/18614	0.00976146853487455	0.0430998173561674	0.0229087095900421	5594/7157	2	MAPK1/TP53
BP	GO:0001657	ureteric bud development	2/29	97/18614	0.00995740887107975	0.0436075141887937	0.0231785640815892	4087/4088	2	SMAD2/SMAD3
BP	GO:1902807	negative regulation of cell cycle G1/S phase transition	2/29	97/18614	0.00995740887107975	0.0436075141887937	0.0231785640815892	1026/7157	2	CDKN1A/TP53
BP	GO:1990874	vascular associated smooth muscle cell proliferation	2/29	97/18614	0.00995740887107975	0.0436075141887937	0.0231785640815892	1026/6714	2	CDKN1A/SRC
BP	GO:0072163	mesonephric epithelium development	2/29	98/18614	0.0101551015719279	0.044233542156969	0.0235113147473207	4087/4088	2	SMAD2/SMAD3
BP	GO:0072164	mesonephric tubule development	2/29	98/18614	0.0101551015719279	0.044233542156969	0.0235113147473207	4087/4088	2	SMAD2/SMAD3
BP	GO:0048661	positive regulation of smooth muscle cell proliferation	2/29	99/18614	0.0103545410947848	0.0448604246894699	0.0238445196369251	3065/6714	2	HDAC1/SRC
BP	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	2/29	99/18614	0.0103545410947848	0.0448604246894699	0.0238445196369251	3065/6714	2	HDAC1/SRC
BP	GO:0007249	I-kappaB kinase/NF-kappaB signaling	3/29	293/18614	0.010423130048077	0.04503683999383	0.0239382891056313	2099/2534/3065	3	ESR1/FYN/HDAC1
BP	GO:0048562	embryonic organ morphogenesis	3/29	294/18614	0.0105196507178488	0.0452468079706507	0.0240498927202	5594/4087/4088	3	MAPK1/SMAD2/SMAD3
BP	GO:0019080	viral gene expression	2/29	100/18614	0.0105557219089946	0.0452468079706507	0.0240498927202	2033/3065	2	EP300/HDAC1
BP	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	2/29	100/18614	0.0105557219089946	0.0452468079706507	0.0240498927202	3065/7157	2	HDAC1/TP53
BP	GO:0001823	mesonephros development	2/29	102/18614	0.0109632853486104	0.0467458288215155	0.0248466625314986	4087/4088	2	SMAD2/SMAD3
BP	GO:0008585	female gonad development	2/29	102/18614	0.0109632853486104	0.0467458288215155	0.0248466625314986	2099/6714	2	ESR1/SRC
BP	GO:0150115	cell-substrate junction organization	2/29	103/18614	0.0111696569724	0.0475004359668379	0.0252477564805496	4088/6714	2	SMAD3/SRC
BP	GO:0048608	reproductive structure development	3/29	301/18614	0.0112099755173679	0.047546772798075	0.0252723857498887	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0032204	regulation of telomere maintenance	2/29	104/18614	0.0113777478842665	0.0481320434056927	0.0255834727846829	5594/6714	2	MAPK1/SRC
BP	GO:0061458	reproductive system development	3/29	305/18614	0.0116160287790375	0.0490117558927533	0.0260510635803066	367/2099/6714	3	AR/ESR1/SRC
BP	GO:0046545	development of primary female sexual characteristics	2/29	106/18614	0.011799065699714	0.0496544014862965	0.0263926469598866	2099/6714	2	ESR1/SRC
CC	GO:0016581	NuRD complex	2/30	17/19518	0.000306181853842658	0.0152686083544458	0.0098067778904558	1457/3065	2	CSNK2A1/HDAC1
CC	GO:0090545	CHD-type complex	2/30	17/19518	0.000306181853842658	0.0152686083544458	0.0098067778904558	1457/3065	2	CSNK2A1/HDAC1
CC	GO:0016580	Sin3 complex	2/30	22/19518	0.0005175799442185	0.0152686083544458	0.0098067778904558	1457/3065	2	CSNK2A1/HDAC1
CC	GO:0070822	Sin3-type complex	2/30	22/19518	0.0005175799442185	0.0152686083544458	0.0098067778904558	1457/3065	2	CSNK2A1/HDAC1
CC	GO:1902554	serine/threonine protein kinase complex	3/30	121/19518	0.000835001416004138	0.0197060334176977	0.0126568635689048	1026/1457/9821	3	CDKN1A/CSNK2A1/RB1CC1
CC	GO:1902911	protein kinase complex	3/30	142/19518	0.00132549134166913	0.0260679963861596	0.0167430485263469	1026/1457/9821	3	CDKN1A/CSNK2A1/RB1CC1
MF	GO:0061629	RNA polymerase II-specific DNA-binding transcription factor binding	9/32	348/18369	5.41699695311781e-09	9.45357362842882e-07	4.02517623445816e-07	367/1387/2033/2099/3065/4087/4088/6714/7157	9	AR/CREBBP/EP300/ESR1/HDAC1/SMAD2/SMAD3/SRC/TP53
MF	GO:0001223	transcription coactivator binding	5/32	43/18369	1.06219928409313e-08	9.45357362842882e-07	4.02517623445816e-07	367/1387/2033/2099/4088	5	AR/CREBBP/EP300/ESR1/SMAD3
MF	GO:0001221	transcription coregulator binding	6/32	111/18369	3.38748962246968e-08	2.00991050933201e-06	8.5578685199234e-07	367/1387/2033/2099/3065/4088	6	AR/CREBBP/EP300/ESR1/HDAC1/SMAD3
MF	GO:0140297	DNA-binding transcription factor binding	9/32	478/18369	8.35836721924341e-08	3.71947341256332e-06	1.58369063101454e-06	367/1387/2033/2099/3065/4087/4088/6714/7157	9	AR/CREBBP/EP300/ESR1/HDAC1/SMAD2/SMAD3/SRC/TP53
MF	GO:0002039	p53 binding	4/32	67/18369	5.38202084131215e-06	0.000191599941950713	8.15801053841e-05	1387/2033/3065/7157	4	CREBBP/EP300/HDAC1/TP53
MF	GO:0001091	RNA polymerase II general transcription initiation factor binding	3/32	26/18369	1.2150357891182e-05	0.000336526470283824	0.000143287438559641	367/2099/7157	3	AR/ESR1/TP53
MF	GO:0008013	beta-catenin binding	4/32	88/18369	1.59597813541085e-05	0.000336526470283824	0.000143287438559641	367/2033/2099/4088	4	AR/EP300/ESR1/SMAD3
MF	GO:0019902	phosphatase binding	5/32	187/18369	1.66960500239997e-05	0.000336526470283824	0.000143287438559641	2885/5594/4087/4088/7157	5	GRB2/MAPK1/SMAD2/SMAD3/TP53
MF	GO:0046875	ephrin receptor binding	3/32	29/18369	1.70153833289574e-05	0.000336526470283824	0.000143287438559641	2534/2885/6714	3	FYN/GRB2/SRC
MF	GO:0097718	disordered domain specific binding	3/32	36/18369	3.29740908756217e-05	0.000586938817586067	0.00024990889926787	2534/4087/7157	3	FYN/SMAD2/TP53
MF	GO:0031490	chromatin DNA binding	4/32	118/18369	5.06337978920851e-05	0.00081934691134465	0.000348864444806711	1387/2033/3065/4088	4	CREBBP/EP300/HDAC1/SMAD3
MF	GO:0048156	tau protein binding	3/32	43/18369	5.65232751853906e-05	0.000838428581916628	0.000356989106434046	2033/2534/4087	3	EP300/FYN/SMAD2
MF	GO:0016922	nuclear receptor binding	4/32	138/18369	9.31316584892464e-05	0.00127518732392968	0.000542953798479817	2033/2099/4088/6714	4	EP300/ESR1/SMAD3/SRC
MF	GO:0140296	general transcription initiation factor binding	3/32	53/18369	0.00010603206409102	0.00134812195772868	0.000574008166507778	367/2099/7157	3	AR/ESR1/TP53
MF	GO:0070410	co-SMAD binding	2/32	11/18369	0.000160129047498513	0.00168959676934636	0.00071940252745676	4087/4088	2	SMAD2/SMAD3
MF	GO:0001098	basal transcription machinery binding	3/32	61/18369	0.000161365983589259	0.00168959676934636	0.00071940252745676	367/2099/7157	3	AR/ESR1/TP53
MF	GO:0001099	basal RNA polymerase II transcription machinery binding	3/32	61/18369	0.000161365983589259	0.00168959676934636	0.00071940252745676	367/2099/7157	3	AR/ESR1/TP53
MF	GO:1990841	promoter-specific chromatin binding	3/32	63/18369	0.000177629022346407	0.00175655366542558	0.000747911673037503	3065/4088/7157	3	HDAC1/SMAD3/TP53
MF	GO:0070411	I-SMAD binding	2/32	14/18369	0.00026407706655286	0.002473985149811	0.00105338220453218	4087/4088	2	SMAD2/SMAD3
MF	GO:0030971	receptor tyrosine kinase binding	3/32	76/18369	0.000309659602064358	0.00275597045837279	0.00117344691308599	2885/7157/7532	3	GRB2/TP53/YWHAG
MF	GO:0051117	ATPase binding	3/32	86/18369	0.00044549530930618	0.00377610309792857	0.00160780262005238	367/2099/6714	3	AR/ESR1/SRC
MF	GO:0051219	phosphoprotein binding	3/32	92/18369	0.000542800508691467	0.00433570702517136	0.00184607277239703	2885/5594/6714	3	GRB2/MAPK1/SRC
MF	GO:0016410	N-acyltransferase activity	3/32	93/18369	0.000560231806623265	0.00433570702517136	0.00184607277239703	79603/1387/2033	3	CERS4/CREBBP/EP300
MF	GO:0016004	phospholipase activator activity	2/32	22/18369	0.000664540693916722	0.00492867681321569	0.00209854955973702	2534/6714	2	FYN/SRC
MF	GO:0005160	transforming growth factor beta receptor binding	2/32	23/18369	0.000727039263419845	0.00497742264956663	0.00211930473547485	4087/4088	2	SMAD2/SMAD3
MF	GO:0043274	phospholipase binding	2/32	23/18369	0.000727039263419845	0.00497742264956663	0.00211930473547485	2534/6714	2	FYN/SRC
MF	GO:0070412	R-SMAD binding	2/32	24/18369	0.000792271831771238	0.00522312540945483	0.00222392093128769	4087/4088	2	SMAD2/SMAD3
MF	GO:0060229	lipase activator activity	2/32	25/18369	0.000860229284328	0.00546860045037085	0.00232844016810586	2534/6714	2	FYN/SRC
MF	GO:0001228	DNA-binding transcription activator activity, RNA polymerase II-specific	5/32	468/18369	0.0011986051505329	0.00713697537676194	0.00303880678371886	367/2099/4087/4088/7157	5	AR/ESR1/SMAD2/SMAD3/TP53
MF	GO:1990782	protein tyrosine kinase binding	3/32	121/18369	0.00120286101855538	0.00713697537676194	0.00303880678371886	2885/7157/7532	3	GRB2/TP53/YWHAG
MF	GO:0001216	DNA-binding transcription activator activity	5/32	472/18369	0.0012447953571825	0.00714529155047567	0.00304234767376847	367/2099/4087/4088/7157	5	AR/ESR1/SMAD2/SMAD3/TP53
MF	GO:0043425	bHLH transcription factor binding	2/32	31/18369	0.00132468888295336	0.00714529155047567	0.00304234767376847	1387/4088	2	CREBBP/SMAD3
MF	GO:0051059	NF-kappaB binding	2/32	31/18369	0.00132468888295336	0.00714529155047567	0.00304234767376847	2033/3065	2	EP300/HDAC1
MF	GO:0019239	deaminase activity	2/32	32/18369	0.00141146713640335	0.00738944559646459	0.00314630445266381	23536/978	2	ADAT1/CDA
MF	GO:0016810	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	3/32	131/18369	0.00151141508490591	0.00768662528895003	0.003272838680097	23536/978/3065	3	ADAT1/CDA/HDAC1
MF	GO:0016814	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines	2/32	35/18369	0.0016876827143472	0.00814700758460417	0.00346886189291248	23536/978	2	ADAT1/CDA
MF	GO:0070851	growth factor receptor binding	3/32	137/18369	0.00171830453499636	0.00814700758460417	0.00346886189291248	2534/2885/6714	3	FYN/GRB2/SRC
MF	GO:0031625	ubiquitin protein ligase binding	4/32	301/18369	0.00176991319386156	0.00814700758460417	0.00346886189291248	1026/4087/4088/7157	4	CDKN1A/SMAD2/SMAD3/TP53
MF	GO:0030291	protein serine/threonine kinase inhibitor activity	2/32	36/18369	0.00178501851572788	0.00814700758460417	0.00346886189291248	1026/7532	2	CDKN1A/YWHAG
MF	GO:0030331	nuclear estrogen receptor binding	2/32	39/18369	0.00209269375406518	0.00931248720559003	0.00396510395507086	2099/6714	2	ESR1/SRC
MF	GO:0044389	ubiquitin-like protein ligase binding	4/32	320/18369	0.00221187428364977	0.0096027712802356	0.00408870214179162	1026/4087/4088/7157	4	CDKN1A/SMAD2/SMAD3/TP53
MF	GO:0001046	core promoter sequence-specific DNA binding	2/32	43/18369	0.00253915721407092	0.0102720450932869	0.00437366792854321	3065/7157	2	HDAC1/TP53
MF	GO:0004402	histone acetyltransferase activity	2/32	43/18369	0.00253915721407092	0.0102720450932869	0.00437366792854321	1387/2033	2	CREBBP/EP300
MF	GO:0004715	non-membrane spanning protein tyrosine kinase activity	2/32	43/18369	0.00253915721407092	0.0102720450932869	0.00437366792854321	2534/6714	2	FYN/SRC
MF	GO:0001222	transcription corepressor binding	2/32	45/18369	0.00277775858314689	0.0107573975563497	0.00458032302813234	2099/3065	2	ESR1/HDAC1
MF	GO:0004879	nuclear receptor activity	2/32	46/18369	0.00290087125115048	0.0107573975563497	0.00458032302813234	367/2099	2	AR/ESR1
MF	GO:0061733	peptide-lysine-N-acetyltransferase activity	2/32	46/18369	0.00290087125115048	0.0107573975563497	0.00458032302813234	1387/2033	2	CREBBP/EP300
MF	GO:0098531	ligand-activated transcription factor activity	2/32	46/18369	0.00290087125115048	0.0107573975563497	0.00458032302813234	367/2099	2	AR/ESR1
MF	GO:0001784	phosphotyrosine residue binding	2/32	47/18369	0.00302651370616613	0.0109942742795423	0.00468118124262001	2885/5594	2	GRB2/MAPK1
MF	GO:0005080	protein kinase C binding	2/32	49/18369	0.00328535349609199	0.0116958584460875	0.00497990424670786	6714/7532	2	SRC/YWHAG
MF	GO:0034212	peptide N-acetyltransferase activity	2/32	51/18369	0.00355420919788193	0.0124048870043722	0.00528179695041277	1387/2033	2	CREBBP/EP300
MF	GO:0045309	protein phosphorylated amino acid binding	2/32	58/18369	0.00457309455023266	0.0156540544219503	0.00666523902058202	2885/5594	2	GRB2/MAPK1
MF	GO:0097110	scaffold protein binding	2/32	66/18369	0.00588303132945238	0.0197581052196703	0.00841267637975316	2534/6714	2	FYN/SRC
MF	GO:0008080	N-acetyltransferase activity	2/32	67/18369	0.00605748551925457	0.0199672670819873	0.00850173406211168	1387/2033	2	CREBBP/EP300
MF	GO:0003684	damaged DNA binding	2/32	71/18369	0.00677874992575193	0.0219384997597063	0.00934105252926582	1387/2033	2	CREBBP/EP300
MF	GO:0016747	acyltransferase activity, transferring groups other than amino-acyl groups	3/32	226/18369	0.00700744875779661	0.0222736764087106	0.00948376523611571	79603/1387/2033	3	CERS4/CREBBP/EP300
MF	GO:0046332	SMAD binding	2/32	77/18369	0.00793009362790368	0.0247641520309974	0.0105441688127251	4087/4088	2	SMAD2/SMAD3
MF	GO:0016746	acyltransferase activity	3/32	253/18369	0.00953786062347065	0.0292713653616858	0.0124632661504517	79603/1387/2033	3	CERS4/CREBBP/EP300
MF	GO:0005126	cytokine receptor binding	3/32	270/18369	0.0113723137498847	0.0343096923301607	0.0146085029436521	2885/4087/4088	3	GRB2/SMAD2/SMAD3
MF	GO:0016407	acetyltransferase activity	2/32	94/18369	0.0116307094044288	0.0345044378998055	0.0146914224055943	1387/2033	2	CREBBP/EP300
MF	GO:0005496	steroid binding	2/32	99/18369	0.0128384511360039	0.0374630213476836	0.0159511385986589	367/2099	2	AR/ESR1
MF	GO:0001094	TFIID-class transcription factor complex binding	1/32	10/18369	0.0172889238815258	0.0480848195454937	0.0204737256491753	7157	1	TP53
MF	GO:0008353	RNA polymerase II CTD heptapeptide repeat kinase activity	1/32	10/18369	0.0172889238815258	0.0480848195454937	0.0204737256491753	5594	1	MAPK1
MF	GO:0070700	BMP receptor binding	1/32	10/18369	0.0172889238815258	0.0480848195454937	0.0204737256491753	6714	1	SRC
MF	GO:0034713	type I transforming growth factor beta receptor binding	1/32	11/18369	0.0190018033649287	0.0497400146905488	0.0211784805305707	4087	1	SMAD2
MF	GO:0035256	G protein-coupled glutamate receptor binding	1/32	11/18369	0.0190018033649287	0.0497400146905488	0.0211784805305707	2534	1	FYN
MF	GO:0097371	MDM2/MDM4 family protein binding	1/32	11/18369	0.0190018033649287	0.0497400146905488	0.0211784805305707	7157	1	TP53
MF	GO:0140666	annealing activity	1/32	11/18369	0.0190018033649287	0.0497400146905488	0.0211784805305707	7157	1	TP53
